Clinical Trial Update: Efficacity and Safety of Metformin XR in CKD Stage 1 to 3 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin extended-release in chronic kidney disease (stages 1–3) has completed, reporting on efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• metformin XR (metformin)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Renal Insufficiency, Chronic | Phase 2 | Status: COMPLETED